| Name | tert-butyl 7-amino-4,4-dimethyl-2,3-dihydroquinoline-1-carboxylate |
|---|---|
| Synonyms |
7-Amino-4,4-dimethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid tert-butyl ester
tert-Butyl 7-amino-3,4-dihydro-4,4-dimethylquinoline-1(2H)-carboxylate |
| Molecular Formula | C16H24N2O2 |
|---|---|
| Molecular Weight | 276.37400 |
| Exact Mass | 276.18400 |
| PSA | 55.56000 |
| LogP | 4.33780 |
| HS Code | 2933499090 |
|---|
|
~93%
873056-12-3 |
| Literature: Vertex Pharmaceuticals Incorported Patent: US2011/98311 A1, 2011 ; |
|
~%
873056-12-3 |
| Literature: US2011/98311 A1, ; |
|
~%
873056-12-3 |
| Literature: US2011/98311 A1, ; |
|
~%
873056-12-3 |
| Literature: US2011/98311 A1, ; |
|
~%
873056-12-3 |
| Literature: US2011/98311 A1, ; |
|
~%
873056-12-3 |
| Literature: US2011/98311 A1, ; |
| Precursor 6 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933499090 |
|---|---|
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |